Real-World Effectiveness of Newly Initiated Once-Weekly Semaglutide (sema OW) by Prescriber Specialty

被引：0
|
作者：
Shivappa, Nitin
Noone, Joshua
Swift, Caroline
Du, Simo
Tan, Hiangkiat
Paprocki, Yurek M.
Willey, Vincent
机构：
来源：
DIABETES | 2021年 / 70卷
关键词：
D O I：
10.2337/db21-1271-PUB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1271-PUB
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Real-World Effectiveness of Once-Weekly Semaglutide (Sema OW) from a US Commercially Insured and Medicare Advantage Population
    Visaria, Jay
    Uzoigwe, Chioma
    Swift, Caroline
    Paprocki, Yurek M.
    Willey, Vincent
    [J]. DIABETES, 2020, 69
  • [2] Real-World Effectiveness of Once-Weekly Semaglutide (sema OW) from a US Commercially Insured and Medicare Advantage Population
    Willey, Vincent
    Shivappa, Nitin
    Noone, Joshua
    Swift, Caroline
    Du, Simo
    Yurek, M. Paprocki .
    Tan, Hiangkiat
    [J]. DIABETES, 2021, 70
  • [3] Real-World Effectiveness of Once-Weekly Semaglutide From a US Commercially Insured and Medicare Advantage Population
    Visaria, Jay
    Uzoigwe, Chioma
    Swift, Caroline
    Dang-Tan, Tam
    Paprocki, Yurek
    Willey, Vincent J.
    [J]. CLINICAL THERAPEUTICS, 2021, 43 (05) : 808 - 821
  • [4] Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from SemaglUtide Real-world Evidence (SURE) Germany
    Menzen, Markus
    Berentzen, Tina Landsvig
    Catarig, Andrei-Mircea
    Pieperhoff, Sebastian
    Simon, Joerg
    Jacob, Stephan
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2023, 131 (04) : 205 - 215
  • [5] Real-World Impact of Once-Weekly Injectable Semaglutide on Glycemic Control and Weight Outcomes in Type 2 Diabetes (RELATE-OW Injectable Semaglutide)
    Amamoo, James
    Doshi, Riddhi P.
    Noone, Joshua
    Tan, Xi
    Xie, Lin
    Gamble, Cory L.
    Guevarra, Mico
    Chen, Justin
    King, Aaron A.
    [J]. DIABETES, 2023, 72
  • [6] Real-world clinical effectiveness of once-weekly semaglutide in patients with type 2 diabetes: a systematic literature review
    Ruan, Zhen
    Jiang, Yixuan
    Shi, Honghao
    Jia, Ruxu
    Ung, Carolina Oi Lam
    Hu, Hao
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023, 16 (02) : 161 - 176
  • [7] Real-World Evaluation of Once Weekly Semaglutide (Serra OW) in Patients Newly Initiating GLP-1 Agonist Therapy
    Shivappa, Nitin
    Swift, Caroline
    Noone, Joshua
    Du, Simo
    Paprocki, Yurek M.
    Tan, Hiangkiat
    Willey, Vincent
    [J]. DIABETES, 2021, 70
  • [8] Real-World Evaluation of Once-Weekly Subcutaneous Semaglutide in Patients with Type 2 Diabetes Mellitus in Spain (SEMA-RW Study)
    Mateos, Irene Caballero
    de Lucas, Maria Dolores Garcia
    Doulatram-Gamgaram, Viyey Kishore
    Moreno-Moreno, Paloma
    Jimenez-Millan, Ana Isabel
    Botana-Lopez, Manuel
    Merino-Torres, Juan Francisco
    Soto-Gonzalez, Alfonso
    Fernandez-Garcia, Jose Carlos
    Morales-Portillo, Cristobal
    [J]. NUTRIENTS, 2024, 16 (15)
  • [9] Efficacy and Safety of Once-Weekly Semaglutide in People with Type 1 Diabetes in Real-World Practice
    Bellido, Virginia
    Herguido, Noelia Gros
    Amuedo, Sandra
    Ariza, Luis Baena
    Alfonso, Soto M.
    [J]. DIABETES, 2023, 72
  • [10] Real-world use of once-weekly semaglutide in patients with type 2 diabetes at an outpatient clinic in Spain
    Garcia de Lucas, Maria Dolores
    Pablo Miramontes-Gonzalez, Jose
    Aviles-Bueno, Beatriz
    Isabel Jimenez-Millan, Ana
    Rivas-Ruiz, Francisco
    Perez-Belmonte, Luis M.
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
12345